CD4 and systemic lupus erythematosus: In addition, the suppression effect against glomerulonephritis in lupus-prone mice by nasal anti-CD3 treatment was found to be associated with a significant reduction in the percentage of IL-17 expressing CD4+ICOS+CXCR5+ T cells [33].